Publications by authors named "Ruimin Hong"

Claim this Profile
S
Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up result.
Tingting Yang, Yetian Dong, Jimin Shi, Mingming Zhang, Delin Kong, Ruimin Hong

J Adv Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive values of baseline F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy.
Pingnan Xiao, Xin Zhao, Linqin Wang, Kanfeng Liu, Yixue Li, Ruimin Hong, Alex Hongsheng Chang

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma.
Yetian Dong, Tingting Yang, Mengyu Zhao, Fengmei Song, Rongrong Chen, Ruimin Hong

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of CBFβ::MYH11 fusion gene in acute lysis pneumopathy: A dual impact on risk and prognosis.
Shuangwei Ying, Luxin Yang, Lulu Zhang, Ruimin Hong, Wenda Luo

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.
Jingjing Feng, Dawei Huo, Ruimin Hong, Xuexiao Jin, Heng Cao, Alex Hongsheng Chang, Zhihong Liu

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancy between WGS-based genotypic and phenotypic drug susceptibility testing of first and second-line drugs for Mycobacterium tuberculosis: Limited impact of unknown resistance mechanisms.
Ruimin Hong, Peng Xu, Wenjie Lai, Chi Wu, Xuecong Zhang

Int J Antimicrob Agents· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Within-host population dynamics of extensively drug-resistant revealed by an over 3-year longitudinal study.
Peng Xu, Xuecong Zhang, Chi Wu, Yiwang Chen, Wenjie Lai, Ruimin Hong

Evol Med Public Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy.
Linghui Zhou, Youqin Feng, Ruimin Hong, Guoqing Wei, Mingming Zhang

Sci China Life Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.
Mingming Zhang, Shan Fu, Jingjing Feng, Ruimin Hong, Guoqing Wei

JAMA Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and evaluation of blood transcriptional biomarker for tuberculosis screening.
Siqi Zhang, Cheng Bei, Meng Li, Jianfeng Zeng, Liangzi Yang, Ruimin Hong

Int J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma.
Chunxiang Jin, Rongrong Chen, Shan Fu, Mingming Zhang, Yuanyin Teng, Ruimin Hong

J Immunother Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.
Tingting Yang, Yetian Dong, Mingming Zhang, Jingjing Feng, Shan Fu, Ruimin Hong

Exp Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells.
Linqin Wang, Yiyun Wang, Xiangjun He, Zhuomao Mo, Mengyu Zhao, Ruimin Hong, Lihong Shen

Cell Rep Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of pre-treatment circulating tumor DNA genomic landscape in patients with relapsed/refractory multiple myeloma undergoing anti-BCMA CAR-T therapy: Insights from tumor cells and T cells.
Rongrong Chen, Chunxiang Jin, Kai Liu, Mengyu Zhao, Tingting Yang, Ruimin Hong

Chin Med J (Engl)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies.
Cheng Zu, Wenxiao Li, Mingming Zhang, Yetian Dong, Shan Fu, Ruimin Hong

BMC Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome.
Jinglei Yu, Fengmei Song, Mingming Zhang, Pingnan Xiao, Jingjing Feng, Ruimin Hong

Mol Biol Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
Yongxian Hu, Mingming Zhang, Tingting Yang, Zhuomao Mo, Guoqing Wei, Ruimin Hong, Hongshan Guo

N Engl J Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies.
Linqin Wang, Yuqi Lv, Linghui Zhou, Shenghao Wu, Yuanyuan Zhu, Ruimin Hong

Exp Hematol Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.
Yongxian Hu, Jingjing Li, Fang Ni, Zhongli Yang, Xiaohua Gui, Ruimin Hong

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.
Tingting Yang, Rongrong Chen, Mingming Zhang, Ruirui Jing, Jia Geng, Ruimin Hong

Cell Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma.
Xueer Xu, Cheng Zu, Mingming Zhang, Pingnan Xiao, Ruimin Hong

Cell Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre study.
Linghui Zhou, Weijun Fu, Shenghao Wu, Kailin Xu, Lugui Qiu, Ruimin Hong

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of CRISPR-based non-viral locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study.
Yongxian Hu, Cheng Zu, Mingming Zhang, Guoqing Wei, Wei Li, Ruimin Hong

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine profiles are associated with prolonged hematologic toxicities after B-cell maturation antigen targeted chimeric antigen receptor-T-cell therapy.
Linqin Wang, Ruimin Hong, Linghui Zhou, Yiyun Wang, Yuqi Lv

Cytotherapy· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-cell therapies in China: rapid evolution and a bright future.
Yongxian Hu, Jingjing Feng, Tianning Gu, Linqin Wang, Yiyun Wang, Ruimin Hong

Lancet Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis